Predictors of cancer patients' utilization of psychooncological support: Examining patient´s attitude and physician´s recommendation.

County-level Factors and Treatment Access Among Insured Women With Opioid Use Disorder.

Urine drug testing in the context of opioid analgesic prescribing for chronic pain: a content analysis of U.S. state laws in 2022.

Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019.

Changes in hospital staff' mental health during the Covid‑19 pandemic: Longitudinal results from the international COPE-CORONA study.

Bleeding and Ischemic Risk Prediction in Patients With High Bleeding Risk (an EVOLVE Short DAPT Analysis).

Cross-modal exposure restores multisensory enhancement after hemianopia.

How are state telehealth policies associated with services offered by substance use disorder treatment facilities? Evidence from 2019 to 2022.

US state laws relevant to incentives for health behavior: A qualitative analysis.

Identifying Optimal Methods for Addressing Confounding Bias When Estimating the Effects of State-level Policies.

Disparities in Perinatal and Emergency Care Receipt Among Women With Perinatal Opioid Use Disorder in Medicaid, 2007 to 2012.

Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009-2018.

Canadian Landscape Assessment of Colorectal Cancer Screening during the COVID-19 Pandemic.

Trends in Geographic Proximity to Substance Use Disorder Treatment.

Four challenges to an effective national nature assessment.